These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11513444)

  • 41. Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds.
    Brooks R; Torchiana D; Vlahakes GJ; Ruskin JN; McGovern BA; Garan H
    J Am Coll Cardiol; 1993 Aug; 22(2):569-74. PubMed ID: 8335831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator.
    Tse HF; Timmermans C; Rodriguez LM; Lau CP; Wellens HJ
    J Cardiovasc Electrophysiol; 2003 Jan; 14(1):32-7. PubMed ID: 12625607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biphasic waveform defibrillation using a three-electrode transvenous lead system in humans.
    Marks ML; Johnson G; Hofer BO; Bardy GH
    J Cardiovasc Electrophysiol; 1994 Feb; 5(2):103-8. PubMed ID: 8186880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized comparison of a 90 uF capacitor three-electrode defibrillation system with a 125 uF two-electrode defibrillation system.
    Bahu M; Knight BP; Weiss R; Hahn SJ; Goyal R; Daoud EG; Man KC; Morady F; Strickberger SA
    J Interv Card Electrophysiol; 1998 Mar; 2(1):41-5. PubMed ID: 9869995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size.
    Block M; Hammel D; Böcker D; Borggrefe M; Budde T; Isbruch F; Scheld HH; Breithardt G
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):207-14. PubMed ID: 8834690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of anodal electrode position on transvenous defibrillation efficacy in humans: a prospective randomized comparison.
    Markewitz A; Kaulbach H; Mattke S; Müller D; Bernutz C; Hoffmann E; Weinhold C; Steinbeck G; Reichart B
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2193-9. PubMed ID: 9309743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial.
    Neuzner J; Liebrich A; Jung J; Himmrich E; Pitschner HF; Winter J; Vester EG; Michel U; Nisam S; Heisel A
    Am J Cardiol; 1999 Mar; 83(5B):34D-39D. PubMed ID: 10089837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems.
    Munsif AN; Saksena S; DeGroot P; Krol RB; Matthew P; Giorgberidze I; Kaushik RR; Mehra R
    Am J Cardiol; 1997 Jun; 79(12):1632-9. PubMed ID: 9202354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.
    Baccillieri MS; Gasparini G; Benacchio L; Zorzi A; Marras E; Zerbo F; Tomasi L; Vaccari D; Pastore G; Bonanno C; Molon G; Zanotto G; Fusco A; Carasi M; Zorzi A; Calzolari V; Ignatiuk B; Cannas S; Vaglio A; Al Bunni M; Pedrini A; Olivieri A; Rampazzo R; Minicuci N; Corrado D; Verlato R
    J Interv Card Electrophysiol; 2015 Jun; 43(1):45-54. PubMed ID: 25690336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Internal defibrillation with minimal skeletal muscle activation: a new paradigm toward painless defibrillation.
    Jayam V; Zviman M; Jayanti V; Roguin A; Halperin H; Berger RD
    Heart Rhythm; 2005 Oct; 2(10):1108-13. PubMed ID: 16188591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter defibrillator implantation with biphasic shocks.
    Schauerte P; Stellbrink C; Schöndube FA; Löser H; Haltern G; Messmer BJ; Hanrath P
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 1):301-6. PubMed ID: 9058867
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passive electrode effect reduces defibrillation threshold in bi-filament middle cardiac vein defibrillation.
    Paisey JR; Yue AM; Bessoule F; Roberts PR; Morgan JM
    Europace; 2006 Feb; 8(2):113-7. PubMed ID: 16627420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of simultaneous versus sequential defibrillation pulsing techniques using a nonthoracotomy system.
    Hsia HH; Kleiman RB; Flores BT; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1222-30. PubMed ID: 7937228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.